This inventor holds 2 USPTO granted patents. Top assignee: Pacesetter, Inc.. Active years: 2016-2017.
Company Filing History:
Years Active: 2016-2017
Title: Michael Kane: Innovator in Cardiac Monitoring Technologies
Introduction
Michael Kane is a notable inventor based in Pewaukee, Wisconsin, who has made significant contributions to the field of cardiac monitoring. With a focus on utilizing pulmonary artery pressure (PAP) for advanced medical applications, Kane has been instrumental in developing technologies that enhance patient care.
Latest Patents
Kane holds 2 patents that showcase his innovative work. His latest patents include "Systems and methods for using pulmonary artery pressure from an implantable sensor to detect mitral regurgitation and optimize pacing delays." This patent describes techniques for using a PAP monitor with an implantable sensor to detect peaks in the PAP signal that correspond to valvular regurgitation, specifically mitral regurgitation. The system also optimizes pacing parameters based on the PAP signal and electrical cardiac signals.
Another significant patent is "Systems and methods for exploiting pulmonary artery pressure obtained from an implantable sensor to detect cardiac rhythm irregularities." This invention allows the PAP monitor to sense variations in PAP during cardiac cycles and detect irregularities such as atrial fibrillation and ventricular tachycardia based on the stability of the intervals in the PAP signal.
Career Highlights
Kane is currently employed at Pacesetter, Inc., a company known for its advancements in cardiac rhythm management devices. His work at Pacesetter has positioned him as a leader in the development of innovative solutions for heart health.
Collaborations
Throughout his career, Kane has collaborated with talented individuals such as Kathleen Kresge and Thao T Ngo. These partnerships have contributed to the success of his projects and the advancement of cardiac monitoring technologies.
Conclusion
Michael Kane's contributions to the field of cardiac monitoring through his patents and work at Pacesetter, Inc. highlight his commitment to improving patient outcomes. His innovative approaches to utilizing pulmonary artery pressure are paving the way for future advancements in cardiac care.